Fill in the form below and our experts will get back to you within 1 business day.
Accelerate your recombinant protein production with our professional Pichia pastoris expression platform. From strain development to large-scale fermentation, we deliver high-quality protein products with exceptional yields and proper eukaryotic post-translational modifications.
Trusted by leading research and pharmaceutical institutions
Custom strain engineering and optimization
Secretory and intracellular expression systems
From bench to industrial fermentation
Our platform combines proven methanol-induced expression systems with cutting-edge CRISPR gene editing technologies for superior protein production.
Our proprietary Pichia pastoris platforms leverage strong methanol-inducible promoters including AOX1 for exceptional protein yields. Multiple host strains with different protease backgrounds ensure optimal expression of your target protein.
Our advanced CRISPR/Cas9 platform enables precise genome editing with 97% homologous recombination efficiency. We develop custom strains optimized for your specific production requirements including glycoengineering and pathway engineering.
Scalable fermentation from shake flasks to 1000L bioreactors with optimized protocols.
SDS-PAGE, Western blot, HPLC, and mass spectrometry verification for every batch.
Dedicated technical team to optimize your expression strategy from project start.
Get a customized quote for your Pichia expression needs.
Industry-leading platforms designed for optimal protein yields and quality.
The strongest methanol-inducible promoter system in Pichia, capable of driving exceptional recombinant protein expression levels exceeding 10 g/L in high-density fermentation.
Advanced CRISPR/Cas9 system with 97% HR efficiency. We knock out non-homologous end joining genes (ku70) and overexpress RAD52/RAD59 for superior homologous recombination.
Random multi-copy integration strategies and site-specific integration using CRISPR to generate high-expressing cell factories with multiple gene copies.
Comprehensive specifications to meet your research and production requirements.
| Parameter | Standard Service | Premium Service | GMP Production |
|---|---|---|---|
| Expression Scale | 1-50 mg | 50 mg - 1 g | 1 g - kg scale |
| Host Strains | GS115, KM71 | SMD1168, PichiaPink | Custom engineered |
| Turnaround Time | 4-6 weeks | 6-10 weeks | 12-16 weeks |
| Promoter Options | AOX1, GAP | AOX1, GAP, FLD1 | Custom promoters |
| Tag Options | His-tag, MBP | His, MBP, GST, SUMO | Tag-free or custom |
| QC Analysis | SDS-PAGE, Western | SEC-HPLC, MS | Full release testing |
Our proven workflow ensures quality and efficiency at every stage.
Codon optimization and vector construction
Transformation and clone screening
Small-scale expression testing
Fermentation optimization
Protein purification and analysis
Our Pichia expression services support research and development in multiple fields.
Pichia pastoris is ideal for producing therapeutic proteins with proper eukaryotic post-translational modifications. Our platform supports the production of antibody fragments, hormones, growth factors, and other biopharmaceutical candidates.
Pichia is widely used for industrial enzyme production including proteases, lipases, cellulases, and other enzymes for food processing, biofuel production, and textile applications. High-cell-density fermentation enables cost-effective large-scale production.
High-quality recombinant proteins for basic research, structural biology, and assay development. Our QC-verified proteins are ideal for crystallization, SPR studies, and antibody production.
Trusted by researchers worldwide for quality and reliability.
"Excellent protein expression results. The Pichia system delivered yields far exceeding our E. coli attempts. The technical team provided valuable consultation throughout the project."
"We needed a glycoengineered cell line for our antibody fragment production. Their CRISPR platform delivered exactly what we needed with proper humanized glycosylation patterns."
"The scale-up from shake flask to fermentation was seamless. QC documentation was comprehensive and the protein quality has been consistent across multiple batches."
Our platform is backed by peer-reviewed research.
Zha J, Liu D, Ren J, Liu Z, Wu X. Journal of Fungi (MDPI). 2023.
Comprehensive review of Pichia pastoris metabolic engineering advances including genetic tools, expression vectors, promoters, CRISPR/Cas9 editing, and adaptive laboratory evolution.
Multiple authors. Bioengineering (MDPI). 2024.
Development of a cost-effective Pichia cell-free protein synthesis system using fructose-1,6-bisphosphate, achieving approximately 2-fold protein yield improvement.
Wu X, Cai P, Gao L, Li Y, Yao L, Zhou YJ. ACS Sustainable Chemistry & Engineering. 2023.
Metabolic engineering of industrial Pichia pastoris for efficient 3-hydroxypropionic acid production from methanol, achieving 48.2 g/L titer.
Multiple authors. Synthetic and Systems Biotechnology. 2023.
Development of a CRISPR/Cas9 system achieving 97% homologous recombination efficiency by knocking out ku70 and overexpressing RAD52/RAD59.
Multiple authors. Scientific Reports (Nature). 2024.
Systematic comparison of three wild-type Pichia pastoris strains showing that diploid Y-11430 produced 43% higher mCherry protein than haploid strains.
Find answers to common questions about our service.
Get a customized quote for your Custom Pichia pastoris protein expression service project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.